HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A study on the relationship between VEGF-C expression and lymphatic metastasis in non-small cell lung cancer].

AbstractBACKGROUND:
It has been known that an intensive relationship exists between the recurrence or metastasis and angiogenesis and lymphangiogenesis in patients with non-small cell lung cancer (NSCLC), but it is uncertain whether there is relationship between VEGF-C expression and angiogenesis and lymphangiogenesis in NSCLC tissues. This study is to explore the relationship among VEGF-C expression and angiogenesis and lymphangiogenesis and lymphatic metastasis in NSCLC tissues.
METHODS:
The expression of VEGF-C was detected in 78 lung cancer tissues with or without lymphatic metastasis by LSAB methods. Microvessel density (MVD) and lymphatic microvessel density (LMVD) were determined in the same patients by CD31 and VEGFR-3 respectively.
RESULTS:
The positive rate of VEGF-C expression was 52.6% (41/78) in NSCLC tissues; VEGF-C expression in lung cancer tissues with lymphatic metastasis (30/43, 69.7%) was significantly higher than that without lymphatic metastasis (11/35, 30.3%) (P < 0.05); LMVD in the group without VEGF-C expression (23.4±2.3) was significantly lower than that with VEGF-C expression (43.2±4.1) (P < 0.05), there was no singificant difference in MVD between the two groups (31.1±1.8 vs 28.1± 3.2) (P > 0.05); the MVD and LMVD in lung cancer tissues with lymphatic metastasis (33.6±1.1 and 41.3±3.3 respectively) were significantly higher than those without lymphatic metastasis (18.7±1.8 and 25.7± 2.1 respectively) (P < 0 05).
CONCLUSIONS:
The results suggest that VEGF-C may play an important role in the lymphatic metastasis of lung cancer through the regulation of lymphangiogenesis.
AuthorsXiaoming Li, Jun Yang, Guosheng Huang, Xuezhao Li
JournalZhongguo fei ai za zhi = Chinese journal of lung cancer (Zhongguo Fei Ai Za Zhi) Vol. 8 Issue 1 Pg. 28-31 (Feb 20 2005) ISSN: 1009-3419 [Print] China
PMID21187020 (Publication Type: English Abstract, Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: